Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Rainbird
    Member
    • Dec 2012
    • 16

    RNA-seq expression measurements and tests

    Got few dumb questions, might already been asked before.

    1, Are the sum of RPKM for all transcripts in a genome supposed to be identical across tissues or samples ?

    2, For detecting differential expression, which method works better: parameter method using negative binomial or other distribution, or the nonparameter method like fisher test? I personally prefer fisher, but I am not sure.

    3, It seems to me the parameter method needs replicates to do the differential expression test. If I have only one RPKM value for each transcript, it means I have no choice but the fisher method, correct?

    Thanks,
    Rainbird
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    2/3. No one will believe results from a Fisher's exact test these days for measuring differential expression. The best you can do with an experiment lacking replicates is to make a ranked list of candidates to verify with qPCR. It'd prove more economical (and less a waste of your time) to run some biological replicates, if that's possible for whatever experiment you're doing.

    1. No, that will vary by tissue and sample. You can see why the sum will vary if you imagine two scenarios. (1) There are only two genes: gene A is 1Kb and has 500,000 reads and gene B is 10Kb and also has 500,000 reads. (2) There are, again, two genes: gene A is 1Kb and has 750,000 reads and gene B is 10Kb and has 250,000 reads. These are, of course, highly contrived examples, but they demonstrate the principal.

    Comment

    • Rainbird
      Member
      • Dec 2012
      • 16

      #3
      Hi dpryan, thanks for your relies.

      2/3, why pepole no longer trust the fisher's results? For me, at least the idea/hypothesis is solid. Parameter methods would be more problematic since the distribution assumption is often invalid.

      1, is this because that the gene length is considered in the RPKM normalization? When trying to measure the expression fold change from RPKM values, should we use: (target gene RPKM in sample A/sum of all gene RPKM in sample A)/(target gene RPKM in sample B/sum of all gene RPKM in sample B) ?

      Thanks,

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        2/3. You have no idea what the biological variance is, so any statistical test will be meaningless. That's why you're best off just ranking things by fold change. You can also take a rough stab at things using DESeq with the "blind" method, which is about the closest you can come to worthwhile statistics (n.b., read the vignette, it's very informative).

        1. Yes, because transcript length is included in RPKM calculations, the sum of them will not be constant across samples or tissues. I'm not really sure what normalizing by the RPKM sum will get you. I would think that more likely to just screw everything up. You can search this forum for other discussions on how to take a stab at creating a ranked list.

        Make your life easier and just sequence some biological replicates.

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by mylaser
          Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
          The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
          Whether you're exploring Kheloyaar for the first time or want to understand...
          Yesterday, 09:27 PM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          Yesterday, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:04 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        7 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-02-2026, 11:08 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Working...